安徽华恒生物科技股份有限公司关于向香港联交所递交H股发行并上市的申请并刊发申请资料的公告

Core Points - Anhui Huaheng Biological Technology Co., Ltd. has submitted an application for the issuance and listing of H-shares on the Hong Kong Stock Exchange on September 30, 2025 [1][3] - The issuance will be limited to qualified overseas investors and domestic qualified investors under Chinese laws [2] - The application is subject to approval from relevant regulatory bodies, including the China Securities Regulatory Commission and the Hong Kong Stock Exchange, and remains uncertain [3] Group 1 - The company has published the application materials on the Hong Kong Stock Exchange website, which may be updated [1][2] - The announcement serves to inform domestic investors about the issuance and listing process [2] - The company will fulfill its information disclosure obligations based on the progress of the application [3]